Hisamitsu Pharmaceutical Co., Inc.

TSE:4530 Stok Raporu

Piyasa değeri: JP¥328.6b

Hisamitsu Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Hisamitsu Pharmaceutical's earnings have been declining at an average annual rate of -4.3%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 1.5% per year. Hisamitsu Pharmaceutical's return on equity is 5.5%, and it has net margins of 9.8%.

Anahtar bilgiler

-4.3%

Kazanç büyüme oranı

-2.4%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi3.4%
Gelir büyüme oranı1.5%
Özkaynak getirisi5.5%
Net Marj9.8%
Son Kazanç Güncellemesi31 Aug 2024

Yakın geçmiş performans güncellemeleri

Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Oct 17
Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Recent updates

Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Oct 17
Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Sep 16
Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 20
Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Jul 26
Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Jul 11
Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Jun 27
Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Jun 13
Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Apr 09
Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Mar 18
Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Gelir ve Gider Dağılımı

Hisamitsu Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSE:4530 Gelir, gider ve kazançlar (JPY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Aug 24150,18514,65062,3418,614
31 May 24145,42014,70859,4888,614
29 Feb 24141,70613,96957,1898,614
30 Nov 23139,27614,33053,3709,785
31 Aug 23135,68813,65552,0159,785
31 May 23134,03314,16051,4459,785
28 Feb 23128,33011,74251,3149,785
30 Nov 22125,41112,96249,58610,613
31 Aug 22121,26111,16049,94310,613
31 May 22118,8258,92749,86310,613
28 Feb 22120,1939,65850,11710,613
30 Nov 21120,3519,74649,98910,766
31 Aug 21120,13510,55949,62510,766
31 May 21117,38911,49948,08210,766
28 Feb 21114,5109,25047,73510,766
30 Nov 20122,7368,99650,81610,504
31 Aug 20130,51714,83951,88510,504
31 May 20136,64116,89452,95110,504
29 Feb 20140,99218,69454,37110,504
30 Nov 19139,91221,29551,01713,032
31 Aug 19137,42517,59451,66413,032
31 May 19139,14217,66553,37813,032
28 Feb 19143,40819,20453,36913,032
30 Nov 18140,89116,60850,62015,076
31 Aug 18143,79118,89149,53515,076
31 May 18145,28818,89749,31615,076
28 Feb 18147,87019,11950,76015,076
30 Nov 17145,74917,89550,79914,378
31 Aug 17144,94120,49549,02714,378
31 May 17143,85319,54049,27314,378
28 Feb 17145,92520,39551,15614,378
30 Nov 16149,29820,80652,19714,965
31 Aug 16153,87117,69456,49714,965
31 May 16160,32518,77859,20914,965
29 Feb 16161,85217,78459,76914,965
30 Nov 15164,08619,62662,66813,718
31 Aug 15162,11918,58664,34413,718
31 May 15158,66718,32164,68513,718
28 Feb 15156,74318,78464,48913,718
30 Nov 14150,44616,64564,06213,924
31 Aug 14150,30517,25063,13813,924
31 May 14151,32617,84162,32513,924
28 Feb 14150,63521,35761,24313,924
30 Nov 13150,54422,97659,71212,662

Kaliteli Kazançlar: 4530 has high quality earnings.

Büyüyen Kar Marjı: 4530's current net profit margins (9.8%) are lower than last year (10.1%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 4530's earnings have declined by 4.3% per year over the past 5 years.

Büyüme Hızlandırma: 4530's earnings growth over the past year (7.3%) exceeds its 5-year average (-4.3% per year).

Kazançlar vs. Sektör: 4530 earnings growth over the past year (7.3%) did not outperform the Pharmaceuticals industry 38.7%.

Özkaynak Getirisi

Yüksek ROE: 4530's Return on Equity (5.5%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y